Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

NCT06309212 is registered in ClinicalTrials.gov with Acibadem University as lead sponsor.

NCT NCT06309212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06309212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults
Lead sponsor
Acibadem University
Phase
Observational
Overall status
Completed
Start date
December 15, 2023
Completion date
January 30, 2024
Enrollment
2,197 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the importance of accurate diagnosis for hpmv, the prevalance of hmpv after covid-19 pandemic